Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression - PubMed (original) (raw)

doi: 10.1189/jlb.1003526. Epub 2004 Jun 24.

Affiliations

• PMID: 15218058
• DOI: 10.1189/jlb.1003526

Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression

Virginia S Carl et al. J Leukoc Biol. 2004 Sep.

Abstract

The regulation of secretory interleukin (IL)-1 receptor antagonist (sIL-1Ra) in response to IL-10 is unique. In contrast to most cytokines, the lipopolysaccharide (LPS)-induced expression of the sIL-1Ra gene is enhanced by concomitant treatment with IL-10. Cotreatment of RAW 264.7 cells with IL-10 + LPS resulted in at least a twofold increase in sIL-1Ra promoter activity and mRNA expression compared with LPS alone; IL-10 alone had no effect on promoter activity or mRNA expression. Examination of sIL-1Ra mRNA expression in bone marrow-derived macrophages (BMDM) resulted in identical results. Transfection of RAW 264.7 cells with the sIL-1Ra/luc reporter and a dominant-negative signal transducer and activator of transcription (STAT)3 (Y705A) expression plasmid inhibited the enhanced response induced by exogenous IL-10 in the presence of LPS. The presence of a functional STAT3-binding site within the proximal sIL-1Ra promoter was demonstrated. As IL-10 is produced by LPS-stimulated macrophages, a role for endogenously produced IL-10 in the response of the sIL-1Ra gene to LPS was suggested. This was confirmed in IL-10-deficient BMDM, which when compared with normal BMDM, had significantly decreased LPS-induced sIL-1Ra mRNA levels that could be restored by exogenously provided IL-10, which induced a fivefold increase of LPS-induced IL-1Ra mRNA in cells from IL-10-/- BMDM. Western blot analysis of phosphorylated STAT3 from wild-type and IL-10-/- BMDM and IL-10 neutralization experiments demonstrated a role for endogenously produced IL-10 in the LPS-induced STAT3 activity. Together, these results demonstrate that endogenously produced IL-10 plays a significant role in LPS-induced sIL-1Ra gene expression via the activation of STAT3.

PubMed Disclaimer

Similar articles

• IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6.
  Ohmori Y, Smith MF Jr, Hamilton TA. Ohmori Y, et al. J Immunol. 1996 Sep 1;157(5):2058-65. J Immunol. 1996. PMID: 8757327
• Intracellular IL-1 receptor antagonist promoter: cell type-specific and inducible regulatory regions.
  Jenkins JK, Drong RF, Shuck ME, Bienkowski MJ, Slightom JL, Arend WP, Smith MF Jr. Jenkins JK, et al. J Immunol. 1997 Jan 15;158(2):748-55. J Immunol. 1997. PMID: 8992991
• Multi-functional roles of Stat3 revealed by conditional gene targeting.
  Takeda K, Akira S. Takeda K, et al. Arch Immunol Ther Exp (Warsz). 2001;49(4):279-83. Arch Immunol Ther Exp (Warsz). 2001. PMID: 11726030 Review.
• Tuning of macrophage responses by Stat3-inducing cytokines: molecular mechanisms and consequences in infection.
  Lang R. Lang R. Immunobiology. 2005;210(2-4):63-76. doi: 10.1016/j.imbio.2005.05.001. Immunobiology. 2005. PMID: 16164013 Review.

Cited by

• Inhibition of JAKs in macrophages increases lipopolysaccharide-induced cytokine production by blocking IL-10-mediated feedback.
  Pattison MJ, Mackenzie KF, Arthur JS. Pattison MJ, et al. J Immunol. 2012 Sep 15;189(6):2784-92. doi: 10.4049/jimmunol.1200310. Epub 2012 Aug 17. J Immunol. 2012. PMID: 22904308 Free PMC article.
• Distinct functions of the mitogen-activated protein kinase-activated protein (MAPKAP) kinases MK2 and MK3: MK2 mediates lipopolysaccharide-induced signal transducers and activators of transcription 3 (STAT3) activation by preventing negative regulatory effects of MK3.
  Ehlting C, Ronkina N, Böhmer O, Albrecht U, Bode KA, Lang KS, Kotlyarov A, Radzioch D, Gaestel M, Häussinger D, Bode JG. Ehlting C, et al. J Biol Chem. 2011 Jul 8;286(27):24113-24. doi: 10.1074/jbc.M111.235275. Epub 2011 May 17. J Biol Chem. 2011. PMID: 21586572 Free PMC article.
• Activation of Toll-Like Receptor 3 Induces Interleukin-1 Receptor Antagonist Expression by Activating the Interferon Regulatory Factor 3.
  Liu Y, Mo CF, Luo XY, Li H, Guo HJ, Sun H, Hu S, Li LM, Wang YT, Yang SX, Chang S, Zou Q. Liu Y, et al. J Innate Immun. 2020;12(4):304-320. doi: 10.1159/000504321. Epub 2019 Dec 20. J Innate Immun. 2020. PMID: 31865314 Free PMC article.
• The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression.
  Kim C, Sano Y, Todorova K, Carlson BA, Arpa L, Celada A, Lawrence T, Otsu K, Brissette JL, Arthur JS, Park JM. Kim C, et al. Nat Immunol. 2008 Sep;9(9):1019-27. doi: 10.1038/ni.1640. Nat Immunol. 2008. PMID: 18677317 Free PMC article.
• Leishmania donovani Exploits Myeloid Cell Leukemia 1 (MCL-1) Protein to Prevent Mitochondria-dependent Host Cell Apoptosis.
  Giri J, Srivastav S, Basu M, Palit S, Gupta P, Ukil A. Giri J, et al. J Biol Chem. 2016 Feb 12;291(7):3496-507. doi: 10.1074/jbc.M115.672873. Epub 2015 Dec 15. J Biol Chem. 2016. PMID: 26670606 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal